These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23054842)

  • 41. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.
    Jansen SA; Newstead GM; Abe H; Shimauchi A; Schmidt RA; Karczmar GS
    Radiology; 2007 Dec; 245(3):684-91. PubMed ID: 18024450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative evaluation for intraductal spread of breast cancer through current imaging tests: their strengths and limitations.
    Kimijima I
    Breast Cancer; 2013 Jan; 20(1):1-2. PubMed ID: 23054844
    [No Abstract]   [Full Text] [Related]  

  • 43. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
    Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
    Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
    Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
    AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
    Allen SD; Osin P; Nerurkar A
    Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative Breast Magnetic Resonance Imaging in Women With Local Ductal Carcinoma in Situ to Optimize Surgical Outcomes: Results From the Randomized Phase III Trial IRCIS.
    Balleyguier C; Dunant A; Ceugnart L; Kandel M; Chauvet MP; Chérel P; Mazouni C; Henrot P; Rauch P; Chopier J; Zilberman S; Doutriaux-Dumoulin I; Jaffre I; Jalaguier A; Houvenaeghel G; Guérin N; Callonnec F; Chapellier C; Raoust I; Mathieu MC; Rimareix F; Bonastre J; Garbay JR
    J Clin Oncol; 2019 Apr; 37(11):885-892. PubMed ID: 30811290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.
    Dillon MF; Quinn CM; McDermott EW; O'Doherty A; O'Higgins N; Hill AD
    J Clin Pathol; 2006 Jul; 59(7):740-3. PubMed ID: 16803949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of grating-based X-ray phase-contrast CT for differentiation of invasive ductal carcinoma and ductal carcinoma in situ in an experimental ex vivo set-up.
    Sztrókay A; Herzen J; Auweter SD; Liebhardt S; Mayr D; Willner M; Hahn D; Zanette I; Weitkamp T; Hellerhoff K; Pfeiffer F; Reiser MF; Bamberg F
    Eur Radiol; 2013 Feb; 23(2):381-7. PubMed ID: 22932738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project.
    Evans A; Clements K; Maxwell A; Bishop H; Hanby A; Lawrence G; Pinder SE;
    Clin Radiol; 2010 Mar; 65(3):181-4. PubMed ID: 20152272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?
    Evans AJ; Pinder SE; Ellis IO; Wilson AR
    J Med Screen; 2001; 8(3):149-51. PubMed ID: 11678555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ
    Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of intraductal carcinoma in situ (DCIS) using grating-based X-ray phase-contrast CT at conventional X-ray sources: An experimental ex-vivo study.
    Hellerhoff K; Birnbacher L; Sztrókay-Gaul A; Grandl S; Auweter S; Willner M; Marschner M; Mayr D; Reiser MF; Pfeiffer F; Herzen J
    PLoS One; 2019; 14(1):e0210291. PubMed ID: 30625220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ.
    Song HM; Styblo TM; Carlson GW; Losken A
    Breast J; 2010; 16(2):141-6. PubMed ID: 20102367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnetic resonance imaging captures the biology of ductal carcinoma in situ.
    Esserman LJ; Kumar AS; Herrera AF; Leung J; Au A; Chen YY; Moore DH; Chen DF; Hellawell J; Wolverton D; Hwang ES; Hylton NM
    J Clin Oncol; 2006 Oct; 24(28):4603-10. PubMed ID: 17008702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of mammography, ultrasound, and MRI in size assessment of ductal carcinoma in situ with histopathologic correlation.
    Baek SH; Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY
    Acta Radiol; 2017 Dec; 58(12):1434-1441. PubMed ID: 28281788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mammographic extent of microcalcifications and oestrogen receptor expression affect preoperative breast carcinoma in situ size estimation.
    Vernet-Tomas M; Mojal S; Gamero R; Nicolau P; Rodríguez-Arana A; Plancarte F; Corominas JM; Serrano-Munne L; Carreras R; Sabadell D
    Breast Cancer; 2017 May; 24(3):466-472. PubMed ID: 27639877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MRI-guided quadrantectomy in patients with ductal carcinoma in situ detected preoperatively by mammographic calcifications.
    Sakakibara M; Yokomizo J; Shiina N; Kazama T; Nakamura R; Fujimoto H; Nagashima T; Takishima H; Nakatani Y; Miyazaki M
    J Am Coll Surg; 2014 Aug; 219(2):295-302. PubMed ID: 24880957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidental detection of clinically unexpected breast lesions by computed tomography.
    Monzawa S; Washio T; Yasuoka R; Mitsuo M; Kadotani Y; Hanioka K
    Acta Radiol; 2013 May; 54(4):374-9. PubMed ID: 23395815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.